MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment

被引：0
|
作者：
Xiaoyue Xu
Shaorong Yu
Wenbo Sun
Xiaobing Qin
Yan Chen
Leilei Zhou
Rui Lou
Shuchen Dong
Bo Shen
Jianzhong Wu
Jialan Zang
Haixia Cao
Meiqi Shi
Qin Zhang
Jifeng Feng
机构：
[1] Jiangsu Institute of Cancer Research,Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital
[2] Nanjing Medical University Affiliated Brain Hospital,Department of Neurosurgery
[3] Xuzhou First People’s Hospital,Department of Oncology, Huai’an First People’s Hospital
[4] Nanjing Medical University,Department of Oncology
[5] The First Hospital of Harbin City,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
Lung adenocarcinoma; MiRNA; Platinum resistance; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 438
页数：7
相关论文
共 50 条
  • [31] Osteopontin expression is associated with platinum-based chemotherapy response and prognosis of patients with advanced non small cell lung cancer
    Zhang, Tao
    Zhang, Dong-ming
    Zhao, Da
    Hou, Xiao-ming
    Yang, Tian-ning
    JOURNAL OF BUON, 2014, 19 (03): : 742 - 748
  • [32] MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
    Irene Ferrer
    Álvaro Quintanal-Villalonga
    Sonia Molina-Pinelo
    Jose Manuel Garcia-Heredia
    Marco Perez
    Rocío Suárez
    Santiago Ponce-Aix
    Luis Paz-Ares
    Amancio Carnero
    Journal of Experimental & Clinical Cancer Research, 37
  • [33] MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
    Ferrer, Irene
    Quintanal-Villalonga, Alvaro
    Molina-Pinelo, Sonia
    Manuel Garcia-Heredia, Jose
    Perez, Marco
    Suarez, Rocio
    Ponce-Aix, Santiago
    Paz-Ares, Luis
    Carnero, Amancio
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [34] MiRNA-21 A biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer
    Gao, Wen
    Lu, Xiao
    Liu, Lingxiang
    Xu, Jing
    Feng, Dongjie
    Shu, Yongqian
    CANCER BIOLOGY & THERAPY, 2012, 13 (05) : 330 - 340
  • [35] Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers
    Takashima, Tsuyoshi
    Taniyama, Daiki
    Sakamoto, Naoya
    Yasumoto, Maika
    Asai, Ryuichi
    Hattori, Takuya
    Honma, Ririno
    Thang, Pham Quoc
    Ukai, Shoichi
    Maruyama, Ryota
    Harada, Kenji
    Kuraoka, Kazuya
    Tanabe, Kazuaki
    Sasaki, Atsuo T.
    Ohdan, Hideki
    Morii, Eiichi
    Murai, Junko
    Yasui, Wataru
    BRITISH JOURNAL OF CANCER, 2021, 125 (01) : 65 - 77
  • [36] Metformin with a carbohydrate-restricted diet in combination with platinum-based chemotherapy in advanced-stage lung adenocarcinoma
    Levy, Benjamin Philip
    Becker, Daniel Jacob
    Piperdi, Bilal
    Chachoua, Abraham
    Gomez, Jorge E.
    Goldstein, Lynn
    Kim, Mimi
    Grossbard, Michael L.
    Perez-Soler, Roman
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapyin advanced nonsmall cell lung cancer
    Booton, Richard
    Ward, Tim
    Heighway, Jim
    Taylor, Pat
    Power, Fiona
    Ashcroft, Linda
    Morris, Julie
    Thatcher, Nicholas
    CANCER, 2006, 106 (11) : 2421 - 2427
  • [38] Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers
    Tsuyoshi Takashima
    Daiki Taniyama
    Naoya Sakamoto
    Maika Yasumoto
    Ryuichi Asai
    Takuya Hattori
    Ririno Honma
    Pham Quoc Thang
    Shoichi Ukai
    Ryota Maruyama
    Kenji Harada
    Kazuya Kuraoka
    Kazuaki Tanabe
    Atsuo T. Sasaki
    Hideki Ohdan
    Eiichi Morii
    Junko Murai
    Wataru Yasui
    British Journal of Cancer, 2021, 125 : 65 - 77
  • [39] Clinical study of platinum-based chemotherapy in the treatment of elderly patients with advanced non-small cell lung cancer
    Zhang, Xiaotong
    Li, Longyun
    Lu, Bo
    CHEST, 2007, 132 (04) : 590S - 591S
  • [40] FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer
    Cortinovis, D. L.
    Andriani, F.
    Livio, A.
    Fabbri, A.
    Perrone, F.
    Marcomini, B.
    Pilotti, S.
    Mariani, L.
    Bidoli, P.
    Bajetta, E.
    Roz, L.
    Sozzi, G.
    CURRENT CANCER DRUG TARGETS, 2008, 8 (05) : 342 - 348
12345